Form 4: Precision BioSciences' General Counsel Increases Stake in Company
SEC Form 4 Filing
Dario Scimeca, General Counsel and Secretary of Precision BioSciences, recently purchased additional shares of the company's common stock through a private placement.
Summary
- Dario Scimeca, the General Counsel and Secretary of Precision BioSciences, acquired 833 shares of common stock on May 8, 2024.
- The shares were purchased at a price of $12 per share through a non-brokered private placement.
- Following the transaction, Scimeca directly owns 6,513 shares of Precision BioSciences.
- The purchase was made pursuant to a definitive subscription agreement with certain members of the company's management.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. An insider purchase is generally a good sign, but the quantity is not large enough to be overwhelmingly positive.
Positives
- The purchase by a key executive signals confidence in the company's prospects.
Industry Context
Insider buying is often seen as a positive sign, indicating that those with the most knowledge of the company believe its stock is undervalued or has potential for growth. However, it's just one factor to consider when evaluating a company's investment potential.
Key Dates
| Date | Description |
|---|---|
| 05/08/2024 | Date of the transaction: Dario Scimeca purchased 833 shares of common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.